AMO Eyes Potential Bid To Nab Bausch & Lomb Before It Goes Private
This article was originally published in The Gray Sheet
Executive Summary
Ophthalmic device firm Advanced Medical Optics is considering a bid for competitor Bausch & Lomb that would trump B&L's existing buyout deal with private equity firm Warburg Pincus
You may also be interested in...
Greatbatch Capacitor Sales, Enpath Purchase Aid 27% Stock Price Jump In Q2
Greatbatch's recent surge in ICD capacitor sales and acquisition of implantable stimulation lead manufacturer Enpath helped drive a 27% jump in Greatbatch's stock price in the second quarter
Greatbatch Capacitor Sales, Enpath Purchase Aid 27% Stock Price Jump In Q2
Greatbatch's recent surge in ICD capacitor sales and acquisition of implantable stimulation lead manufacturer Enpath helped drive a 27% jump in Greatbatch's stock price in the second quarter
Bausch & Lomb bidding escalates
Advanced Medical Optics offers to buy rival ophthalmic device firm Bausch & Lomb for $75 per share in cash and stock - or $4.3 billion - to trump private equity firm Warburg Pincus' $65-per-share cash offer announced in May. B&L said July 5 it will consider AMO's proposal, which is contingent in part on additional due diligence. AMO indicated it was considering a bid shortly after the original Warburg agreement (1"The Gray Sheet" May 28, 2007, p. 21). However, AMO management's focus on a subsequent recall of its Complete MoisturePlus contact lens solution had threatened to derail the effort (2"The Gray Sheet" June 4, 2007, p. 10)...